Colgate-Palmolive (India) Limited has announced its financial results for the quarter and year ended March 31, 2026. The company reported a 9% year-on-year topline growth for the fourth quarter, alongside the declaration of a second interim dividend of Rs. 24 per equity share. The board has also approved the re-appointment of Mr. Jacob Sebastian Madukkakuzy as Whole-time Director and Chief Financial Officer for a five-year term.
Quarterly Financial Performance
For the fourth quarter ended March 31, 2026, Colgate-Palmolive (India) witnessed a strong rebound in growth. The company achieved a 9% year-on-year increase in net sales, which rose to Rs. 1,583 crore from Rs. 1,452 crore in the same period last year. Domestic business growth reached 9.2%, driven by a balanced strategy of volume growth and pricing, particularly within the premium portfolio.
Full Year Overview
For the full financial year 2025-26, the company reported net sales of Rs. 5,984 crore. Net profit after tax stood at Rs. 1,325 crore. The financial performance for the year faced impact from inverted duty structure charges related to GST changes and interest on tax refunds from the previous year.
Dividend Announcement
The Board of Directors has declared a second interim dividend of Rs. 24 per equity share of Re. 1 face value. This follows the first dividend, bringing the total dividend for the financial year 2025-26 to Rs. 48 per share. The record date for the second interim dividend is set for June 1, 2026, with payment scheduled to commence on June 17, 2026.
Leadership Continuity
The company confirmed the re-appointment of Mr. Jacob Sebastian Madukkakuzy as the Whole-time Director and Chief Financial Officer. His new term is set for 5 years, commencing on October 28, 2026, and concluding on October 27, 2031, subject to shareholder approval at the upcoming 85th Annual General Meeting scheduled for July 29, 2026.
Future Outlook
Management remains committed to its ‘Funding the Growth’ cost savings initiatives while prioritizing innovation. Recent product launches, such as the ‘Brilliant Star’ mid-tier whitening toothbrush, and ongoing strategic partnerships with elite athletes are key components of the company’s efforts to sustain growth momentum and category consumption in the oral care market.
Source: BSE
